Can Alzheimer’s disease be delayed or stopped before the symptoms begin? A new clinical trial strives to find answers.

<p>The AHEAD clinical trial will assess whether the new Alzheimer’s drug, lecanemab, can delay the onset of dementia in persons who are at high risk of developing the disease. &nbsp; The Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, part of The University of Texas Health Science Center at San Antonio (UT Health San Antonio), [&hellip;]</p>